ProfileGDS5822 / ILMN_2944843
TitleAnti-CTLA-4 immunotherapy effect on αSMA+ myofibroblast late-depleted pancreatic ductal adenocarcinoma model
OrganismMus musculus


control myofibroblast depletion untreated anti-CTLA4 antibody GSM1276599 GSM1276600 GSM1276601 GSM1276602 GSM1276603 GSM1276604 GSM1303940 GSM1303941 GSM1303942 92% 94% 92% 93% 94% 96% 92% 94% 94% sort by protocol sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM1276599PDAC Late Ablation Control 168492
GSM1276600PDAC Late Ablation Control 2893.794
GSM1276601PDAC Late Ablation Control 3796.492
GSM1276602PDAC Late Ablation 1709.593
GSM1276603PDAC Late Ablation 21017.494
GSM1276604PDAC Late Ablation 31668.296
GSM1303940PDAC Late Ablation_anti-CTLA4 1646.892
GSM1303941PDAC Late Ablation_anti-CTLA4 21006.294
GSM1303942PDAC Late Ablation_anti-CTLA4 31033.494